Cartagenia Partners with CollabRx to Provide Pathology Laboratories and Cancer Centers Access to Personalized Information on Therapeutic Options

Cartagenia, leader in providing genetic labs and clinicians with software-based workflow support for variant assessment, lab reporting, and access of relevant knowledge-bases, today announced a partnership with CollabRx that will provide Cartagenia's customers access to CollabRx's industry-leading treatment information resources and services.

Please to read the entire article.

You must be logged in to post a comment Login